ISLAMABAD: The Economic Coordination Committee (ECC) of the federal cabinet on Monday approved increasing the prices of 49 medicines under Minimum Retail Price (MRP).
However, the government claimed that the prices of these 49 medicines were 24% to 77% less compared to other regional countries, including India, Bangladesh, Nepal, and Sri Lanka.
The medicines included Taflotan Ophthalmic Solution 0.0015% w/v OBS Pakistan, MultiBic 2 mmo1/1 potassium solution for haemodialysis/ haemofiltration by M/s Fresenius Medical Care Pakistan (Private) Ltd, MultiBic 4 mmo1/1 potassium solution for haemodialysis/ haemofiltration, MultiBic 3 mmo1/1 potassium solution for haemodialysis/hemofiltration and others.
The ECC also approved a supplementary grant of Rs402.251 billion for debt servicing on Chinese and Saudi loans mainly because of fluctuations in the exchange rate.
The exchange rate was envisaged at Rs186 against the US dollar but the depreciation in the exchange rate increased to an average of Rs235 against the US dollar.
